Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/47454
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ugur N. | - |
dc.contributor.author | Harputlu E. | - |
dc.contributor.author | Sezer C.V. | - |
dc.contributor.author | Demirdogen R.E. | - |
dc.contributor.author | Ince M. | - |
dc.contributor.author | Unlu C.G. | - |
dc.contributor.author | Yurt F. | - |
dc.date.accessioned | 2023-01-09T21:24:45Z | - |
dc.date.available | 2023-01-09T21:24:45Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1773-2247 | - |
dc.identifier.uri | https://doi.org/10.1016/j.jddst.2021.102778 | - |
dc.identifier.uri | https://hdl.handle.net/11499/47454 | - |
dc.description.abstract | The uniformly dispersed hollow mesoporous carbon nanoparticles (HMCNPs) were successfully synthesized by hard-template methods, and D-NMAPPD (B13) was successfully loaded onto the nanoparticle surface for the first time. Structural properties of bare and B13 loaded HMCNPs (HMCNs-B-13) were investigated by Fourier Transform Infrared Spectroscopy (FT-IR), Field Emission-Scanning Electron Microscopy (FE-SEM), Thermal Gravimetric Analysis (TG). The amount of drug released was determined via in vitro drug release studies at 37 °C in SBF through UV–Vis spectrometric and thermal analyses. TG data revealed that the proportion of loaded B-13 was 33.60%. Their ability to induce apoptosis in cultures of A549 human lung adenocarcinoma cells was investigated, and the inhibitory effect of HMCNPs-B-13 on lung cancer cell proliferation was determined in vitro. The IC50 values determined after application periods of 24 and 48 h were found to be 16.13 ?g/mL and 12.96 ?g/mL, respectively. The role of HMCNPs-B-13 on the morphology and ultrastructure of A549 cells was also investigated by confocal microscopy and Transmission electron microscopy (TEM) studies. © 2021 Elsevier B.V. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Editions de Sante | en_US |
dc.relation.ispartof | Journal of Drug Delivery Science and Technology | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cytotoxicity | en_US |
dc.subject | D-NMAPPD | en_US |
dc.subject | Hollow mesoporous carbon nanoparticles | en_US |
dc.subject | Lung cancer | en_US |
dc.subject | 1 (4' nitrophenyl) 2 (tetradecanoylamido) 1,3 propanediol | en_US |
dc.subject | antineoplastic agent | en_US |
dc.subject | carbon nanoparticle | en_US |
dc.subject | ceramide derivative | en_US |
dc.subject | hollow mesoporous carbon nanoparticle | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | A-549 cell line | en_US |
dc.subject | antineoplastic activity | en_US |
dc.subject | antiproliferative activity | en_US |
dc.subject | apoptosis | en_US |
dc.subject | Article | en_US |
dc.subject | biological activity | en_US |
dc.subject | cell ultrastructure | en_US |
dc.subject | cell viability | en_US |
dc.subject | chromatin condensation | en_US |
dc.subject | confocal microscopy | en_US |
dc.subject | controlled study | en_US |
dc.subject | drug cytotoxicity | en_US |
dc.subject | drug release | en_US |
dc.subject | field emission scanning electron microscopy | en_US |
dc.subject | Fourier transform infrared spectroscopy | en_US |
dc.subject | human | en_US |
dc.subject | human cell | en_US |
dc.subject | IC50 | en_US |
dc.subject | immobilization | en_US |
dc.subject | in vitro study | en_US |
dc.subject | lung adenocarcinoma | en_US |
dc.subject | transmission electron microscopy | en_US |
dc.title | Investigation of in vitro biological activities of hollow mesoporous carbon nanoparticles bearing D-NMAPPD on human lung adenocarcinoma cells | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 67 | en_US |
dc.identifier.doi | 10.1016/j.jddst.2021.102778 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 57205261202 | - |
dc.authorscopusid | 55348334900 | - |
dc.authorscopusid | 56422535700 | - |
dc.authorscopusid | 26656515500 | - |
dc.authorscopusid | 36703032500 | - |
dc.authorscopusid | 57199154152 | - |
dc.authorscopusid | 6602719646 | - |
dc.identifier.scopus | 2-s2.0-85121591601 | en_US |
dc.identifier.wos | WOS:000788084600002 | en_US |
dc.identifier.scopusquality | Q1 | - |
item.cerifentitytype | Publications | - |
item.openairetype | Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
crisitem.author.dept | 20.03. Biomedical Engineering | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
1
checked on Nov 23, 2024
Page view(s)
34
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.